Impact of Dapagliflozin on Left ventricular hemodynamics and Exercise-induced Pulmonary hypertension evaluated by echocardiography in patients with type 2 diabetes; an open-label prospective randomized controlled trial
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Mar 2018
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Hypertension in diabetes; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms IDOL-EPOC
- 02 Mar 2018 Status changed from recruiting to active, no longer recruiting.
- 11 Nov 2016 Status changed from not yet recruiting to recruiting.
- 12 Sep 2016 New trial record